Topic Archives: Boston Scientific (BSX)

[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. Enjoy!] Readers not familiar with Stock Gumshoe usually arrive wondering if the salivation provoked by stock promotional writers for certain companies is justified. […]

Comments

  • Avatar

    $BSX Boston Scientific to buy Symetis for $435 mln. Valve implantation. Competition with Metronics and Edwards....

  • DrKSSMDPhD

    Trade notice: Exit Boston Scientific $BSX Rationale: Extended epoch of growth beginning in 2014 appears to have co...

  • DrKSSMDPhD

    One more sign that ardor for dealmaking is returning: Boston Scientific snaps up tiny Georgian endoscopy tech company En...

  • SoGiAm

    Author: ed226914 Comment Link: http://www.stockgumshoe.com/reviews/alternative-energy-speculator/nick-hodges-the-one-an...

  • Avatar

    NMKEF, will be the first to produce battery grade LI on a commercial scale. bought it at different times from .30 to $1...

  • Avatar

    I bought NMKEF at .30, might want to take a look at share price now, They go into full commercial production in H2, 2018...

  • Avatar

    This is a bit of an aside, but I've been thinking of putting together a tracking index of the biotechs followed here. W...

  • DrKSSMDPhD

    Fine coverage from Tracy Staton at Fierce of Salix's woes: http://www.fiercepharma.com/marketing/headline?utm_medium=...

  • Avatar

    TRXC Board Email addresses Paul Laviolette Chairman of the Board EMAIL paul.laviolette@svlsa.com LaViolette brings n...

  • Avatar

    Sandra, if you really suffer from chronic back pain, why not consider spinal cord stimulation with an implantable neuros...

  • Avatar

    Porter S had predicted the imminent demise of G about two years ago and had promoted Boston Scientific as a great BUY! ...

  • DrKSSMDPhD

    One biotech company we semi-follow here has had the most upgrades of any in the last 90 days: Boston Scientific ($BSX). ...

  • Avatar

    Good news for Celladon? From the little I just read online about Scott Garrett it looks like he has a lot of experience...

  • DrKSSMDPhD

    David B: To be fair, my mind is not closed about Medifocus. My main "issue" there is that Boston Scientific (I have shar...

  • Dr. KSS, MD, PhD

    When I first heard about the MedTronic Covidien tie up I was thinking this is like a frog marrying an apple. I was conf...

  • arch1

    Paul ,try BSX Boston scientific. I have seen that teased before but I don't know of ant new developments.....

  • karmaswimswami

    I am quite confused by the Prolieve situation where it concerns Medifocus. Something doesn't add up. I have been aware o...

  • Avatar

    I've been a subscriber for almost a year. Earlier this year Porter recommended BSX (Boston Scientific) and stated that h...

  • Avatar

    Just remember one thing. Porter Stansberry is the same guy that told everyone that would listen to buy shares in Boston...

  • Avatar

    The thing that really jumps out at me is the fact that this company only has 22 million shares of stock outstanding. Wh...

  • Avatar

    Yesterday (the 19th), you guessed that the latest Stansberry "Got to Act Before Today (the 20th)"-- because of an allege...

  • Avatar

    It's Boston Scientific (BSX) -- wrote about them a few months ago when Porter started this campaign....

  • Avatar

    I took the following from an RTT News story about Johnson and Johnson that was posted on-line on October 13, 2009: "Amon...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info